Welcome to LookChem.com Sign In|Join Free

CAS

  • or
C7H13NO2 is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

1511292-06-0

Post Buying Request

1511292-06-0 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

1511292-06-0 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 1511292-06-0 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,5,1,1,2,9 and 2 respectively; the second part has 2 digits, 0 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 1511292-06:
(9*1)+(8*5)+(7*1)+(6*1)+(5*2)+(4*9)+(3*2)+(2*0)+(1*6)=120
120 % 10 = 0
So 1511292-06-0 is a valid CAS Registry Number.

1511292-06-0Downstream Products

1511292-06-0Relevant articles and documents

Pd-catalyzed coupling of γ-C(sp3)-H bonds of oxalyl amide-protected amino acids with heteroaryl and aryl iodides

Han, Jian,Zheng, Yongxiang,Wang, Chao,Zhu, Yan,Huang, Zhi-Bin,Shi, Da-Qing,Zeng, Runsheng,Zhao, Yingsheng

, p. 5681 - 5689 (2016)

Pd-catalyzed regioselective coupling of γ-C(sp3)-H bonds of oxalyl amide-protected amino acids with heteroaryl and aryl iodides is reported. A wide variety of iodides are tolerated, giving the corresponding products in moderate to good yields. Various oxalyl amide-protected amino acids were compatible in this C-H transformation, thus representing a practical method for constructing non-natural amino acid derivatives.

FUSED MORPHOLINOPYRIMIDINES AND METHODS OF USE THEREOF

-

Paragraph 1149, (2017/05/14)

The present disclosure relates to Fused Morpholinopyrimidines, pharmaceutical compositions comprising an effective amount of a Fused Morpholinopyrimidine and methods for using a Fused Morpholinopyrimidine in the treatment of a neurodegenerative disease, comprising administering to a subject in need thereof an effective amount of a Fused Morpholinopyrimidine.

FUSED MORPHOLINOPYRIMIDINES AND METHODS OF USE THEREOF

-

Paragraph 0842, (2015/08/03)

The present disclosure relates to Fused Morpholinopyrimidines, pharmaceutical compositions comprising an effective amount of a Fused Morpholinopyrimidine and methods for using a Fused Morpholinopyrimidine in the treatment of a neurodegenerative disease, comprising administering to a subject in need thereof an effective amount of a Fused Morpholinopyrimidine.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 1511292-06-0